Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
NCT04085029 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2026-02-05
Summary
The purpose of this study is to provide a registry of participants in order to assess the acute adverse event rates following ablative radiotherapy for metastatic disease.
Conditions
- Oligometastasis
- Metastatic Cancer
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Joseph Salama, MD · Duke University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-26
- Primary Completion
- 2029-09-30
- Completion
- 2029-09-30
Countries
- United States
Study Locations
More Related Trials
-
Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer
NCT04989725 ·Status: RECRUITING ·Phase: PHASE2
-
A Study For Using Radiosurgery On Limited Metastases
NCT00178399 ·Status: COMPLETED ·Phase: NA
-
Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy
NCT05111197 ·Status: UNKNOWN ·Phase: PHASE3
-
Rapid Radiation Therapy for Painful Osseous Metastatic Disease
NCT01391234 ·Status: COMPLETED ·Phase: NA
-
Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer
NCT03113851 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular Carcinoma
NCT03416803 ·Status: UNKNOWN ·Phase: NA
-
The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease
NCT04122469 ·Status: RECRUITING ·Phase: NA
-
Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect
NCT03825510 ·Status: COMPLETED ·Phase: PHASE2
-
Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases
NCT02798029 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases
NCT01461252 ·Status: WITHDRAWN ·Phase: PHASE1
-
Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease
NCT01427322 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Study of Cryoablation for Metastatic Lung Tumors
NCT01957787 ·Status: COMPLETED ·Phase: NA
-
Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases
NCT00168129 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor
NCT02086721 ·Status: COMPLETED ·Phase: PHASE1
-
Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab
NCT04748419 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases
NCT04397978 ·Status: RECRUITING
-
A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain
NCT00802659 ·Status: TERMINATED ·Phase: NA
-
A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer
NCT04881981 ·Status: UNKNOWN ·Phase: PHASE1
-
Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)
NCT01282450 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor
NCT00406289 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of Stereotactic Ablative Radiotherapy for Metastatic Lymphadenopathy
NCT02803151 ·Status: UNKNOWN ·Phase: NA
-
Registry Study of Proton Radiotherapy in Lymphoma
NCT04613388 ·Status: RECRUITING
-
A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy Using Extensive Pleural Resection
NCT04028570 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma
NCT01247298 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients
NCT05229575 ·Status: UNKNOWN ·Phase: NA